The deal covers global rights to three brands – Zinnat (cefuroxime axetil), Zinacef (cefuroxime ... but in the meantime GSK has agreed to continue to supply the drug for the next four years.

Teva Pharmaceutical Industries Ltd. ADR-3.78% $21.4B ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

After hours: January 29, 7:57:49 PM EST Vertex Baseline Delta ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

After hours: January 24 at 7:46:59 p.m. EST ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...